Personlig profil
Expertise
Lars Erik Kristensen is chief scientific officer (CSO) at the parker institute. He operates as part leader and part doer with the responsibility of ensuring that the scientific projects support the strategy elements of the Parker Institute.
"
Primære forskningsområder
Lars Erik Kristensens’ current research activities are focused around efficacy and tolerability of anti-TNF treatment and other 2nd generation biologicals in chronic arthritis both in controlled trial settings and observational cohort studies.
Aktuel forskning
Over the recent years, especially spondylarthritis have been studied also from an epidemiologic perspective. Exploring different outcome measures have gained increasing focus addressing interventions from a patient, societal, and clinical perspective.
Eksterne ansættelser
Københavns Universitet
2005 → …
Fingeraftryk
- 1 Lignende profiler
Samarbejde og topforskningsområder i de sidste fem år
-
Do cognitive bias and heuristics influence improvement in knee pain in patients with knee osteoarthritis treated with open label placebo? The CHIPS study - An exploratory study using questionnaire and group concept mapping
Annfeldt, T. K., Ginnerup-Nielsen, E., Wæhrens, E. E., Vase, L., Kristensen, L. E. & Jørgensen, T. S., mar. 2025, I: Osteoarthritis and Cartilage Open. 7, 1, 100574.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Effect of weight loss and liraglutide on neutrophil gelatinase-associated lipocalin levels among individuals with overweight and knee osteoarthritis: Exploratory analyses of a randomized controlled trial
Poulsen, A. S., Stisen, Z. R., Skougaard, M., Christensen, R., Overgaard, A., Gudbergsen, H., Jacobsen, S., Balslev-Clausen, A. P., Henriksen, M., Kristensen, L. E. & Bliddal, H., mar. 2025, I: Osteoarthritis and Cartilage Open. 7, 1, 100562.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
4 Citationer (Scopus) -
Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study
Berg, J. I., Nielsen, S. M., Malm, E., Ioannidis, J. P. A., Furst, D. E., Smolen, J. S., Taylor, P. C., Kristensen, L. E., Tarp, S., Ellingsen, T. & Christensen, R., mar. 2025, I: Annals of the Rheumatic Diseases. 84, 3, s. 398-408 11 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
2 Citationer (Scopus) -
Retention rate of a novel autoinjector e-Device introduced to patients with chronic arthritis treated with certolizumab pegol in clinical practice: an observational implementation study
Jørgensen, T. S., Hansen, R. L., Pouls, B., Van den Bemt, B., Sjöwall, C. & Kristensen, L. E., jan. 2025, I: Scandinavian Journal of Rheumatology. 54, 1, s. 25-32 8 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Synergistic Improvements in Synovitis, Enthesitis, and Patient-Reported Outcomes for Patients with Psoriatic Arthritis Treated with Ixekizumab in SPIRIT Trials
Kristensen, L.-E., McGonagle, D., Rudwaleit, M., Kameda, H., Würtzen, P. A., Ngantcha, M., Holzkämper, T. & Smolen, J., apr. 2025, I: Rheumatology and Therapy. 12, 2, s. 381-395 15 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review